|
|
Volumn 75, Issue 5, 2001, Pages 865-870
|
|
Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition
|
|
Author keywords
Contraception; Etonogestrel; Follicular diameter; Ovulation inhibition; Pharmacodynamics; Serum hormone levels; Vaginal ring
|
|
Indexed keywords
DESOGESTREL PLUS ETHINYLESTRADIOL;
ESTRADIOL;
ETHINYLESTRADIOL;
ETONOGESTREL;
FOLLITROPIN;
LUTEINIZING HORMONE;
PROGESTERONE;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTRACEPTION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DRUG SAFETY;
ENDOMETRIUM;
ESTRADIOL BLOOD LEVEL;
FEMALE;
FOLLITROPIN BLOOD LEVEL;
HORMONE BLOOD LEVEL;
HUMAN;
HUMAN EXPERIMENT;
LUTEINIZING HORMONE BLOOD LEVEL;
NORMAL HUMAN;
OVARY FOLLICLE DEVELOPMENT;
OVARY FUNCTION;
OVULATION INHIBITION;
PATIENT COMPLIANCE;
PHARMACODYNAMICS;
PRIORITY JOURNAL;
PROGESTERONE BLOOD LEVEL;
RANDOMIZED CONTROLLED TRIAL;
ULTRASOUND;
VAGINA RING;
ADOLESCENT;
ADULT;
CONTRACEPTIVE DEVICES, FEMALE;
CONTRACEPTIVES, ORAL, SYNTHETIC;
CROSS-OVER STUDIES;
DESOGESTREL;
ENDOMETRIUM;
ESTRADIOL CONGENERS;
ETHINYL ESTRADIOL;
FEMALE;
FOLLICLE STIMULATING HORMONE;
HUMANS;
LUTEINIZING HORMONE;
OVARIAN FOLLICLE;
OVULATION;
PROGESTERONE;
TIME FACTORS;
VINYL COMPOUNDS;
|
|
EID: 0035029575
PISSN: 00150282
EISSN: None
Source Type: Journal
DOI: 10.1016/S0015-0282(01)01689-2 Document Type: Article |
|
Times cited : (177)
|
|
References (5)
|
